US Patent Issued to The General Hospital on Dec. 2 for "Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation" (Massachusetts Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,309, issued on Dec. 2, was assigned to The General Hospital Corp..

"Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation" was invented by Patricia K. Donahoe (Boston) and David Pepin (Somerville, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "One aspect of the invention provides a method of ovarian protection by administering to a female subject a composition comprising Mullerian inhibiting substance (MIS). Ovarian protection can be an induced arrest of folliculogenesis to preserve fertility. In some embodiments, ovarian protection is oncoprotection, the protection of...